跳至主要内容
临床试验/NCT03582020
NCT03582020已完成不适用

Nutritional Evaluation - NuEva Study

University of Jena2 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2018年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55
试验地点
2
主要终点
blood lipids after implementation of menu plans

研究概览

简要总结

The NuEva study focusses on the development and the validation of nutritional concepts for healthy persons with different dietary habits, such as Western diet, flexitarians, vegetarians, as well as vegans. The practical nutritional concepts will ensure an optimal intake of macro- and micronutrients according to the guidelines of the nutritional societies and contribute to prevention and therapy of civilization disease, such as cardiovascular diseases. In addition, the contribution of the nutritional habits on health and disease status (focus cardiovascular diseases) will be evaluated.

详细描述

The implementation of the vegetarian and vegan lifestyle is characterized by omitting defined food groups such as meat, sausage (vegetarians) or additionally dairy products and honey (vegans). This bears the risk of undersupply with valuable nutrients. Critical nutrients in the vegetarian-vegan lifestyle are low intakes of vitamin B12, vitamin D, n-3 LC-PUFA, calcium, iron, zinc as well as a high phytate intake.

The hype of the vegetarian and vegan lifestyle in combination with hints for critical nutrients following the adoption to these eating habits highlights the need of a comprehensive data collection that allows for making recommendations based on reliable scientific evidence.

To address this need, the proposed NuEva study will enroll 55 vegetarians (adherence of at least 1 year), 55 vegans (adherence of at least 1 year), as well as 55 flexitarians (characteristics: selected and rare meat/sausage consumption, once or twice per week, adherence of at least 1 year). Further, 55 participants who consume a Western diet (adherence of at least 1 year) will be recruited as control group).

Run-in/screening To record and document the varieties in dietary practices within and among each group, the 14 d run-in phase of the proposed study will include individual assessments of dietary habits using self-reports (FFPs, lifestyle questionnaires).

Screening (sampling): comprehensive nutrient analyses (vitamins, minerals, trace elements) in plasma/serum samples

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI < 30 kg/m2
  • Participants must be subjectively healthy
  • Adherence to one of the four groups (Western diet, flexitarians, vegetarians, vegans) confirmed by lifestyle and nutrition questionnaires, food frequency protocol (7 d)
  • Precondition: stable eating habits for at least two years before enrollment

排除标准

  • Subjects with any acute or chronic disease (tumor, infection, other), gastrointestinal diseases, diabetes mellitus (type I, II), chronic renal disease, diseases of the parathyroids, diseases necessitating regular phlebotomies
  • Intake of additional dietary supplements (e.g. fish oil capsules, vitamins, minerals etc.)
  • Weight loss or weight gain (> 3 kg) during the last three months before study begin
  • Pregnancy or lactation
  • Transfusion of blood in the last three months before blood sample taking

结局指标

主要结局

blood lipids after implementation of menu plans

时间窗: change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks)

LDL/HDL ratio and blood lipids (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides in mmol/l) after implementation of menu plans

次要结局

  • vitamin B12(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • iron(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • kalium(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • lipoprotein(a)(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • diastolic blood pressure(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • vitamin A(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • folic acid(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • transferin(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • homoarginine(change from baseline after 48 weeks (optional after 96 weeks))
  • glucose(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • fibrinogen(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • Basal metabolic rate (BMR)(change from baseline after 48 weeks (optional after 96 weeks))
  • vitamin D(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • vitamin B1(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • metabolic profiling(change from baseline after 48 weeks (optional after 96 weeks))
  • high sensitive c-reactive protein(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • asymmetric dimethylarginine(change from baseline after 48 weeks (optional after 96 weeks))
  • cystatin C(change from baseline after 48 weeks (optional after 96 weeks))
  • Anthropometric data(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • systolic blood pressure(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • Fatty acid distribution in plasma lipids und erythrocyte lipids(change from baseline after 48 weeks (optional after 96 weeks))
  • calcium(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • apolipoproteins(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • homocysteine(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • HbA1c(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • Bioelectrical impedance(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • vitamin E(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • vitamin B6(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • ferritin(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • trimethylamine N-oxide(change from baseline after 48 weeks (optional after 96 weeks))
  • insulin(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • alpha prothrombin time(change from baseline after 12, 24, 36 and 48 weeks (optional after 60, 72, 84, 96 weeks))
  • NT-pro-BNP(change from baseline after 48 weeks (optional after 96 weeks))
  • troponin(change from baseline after 48 weeks (optional after 96 weeks))
  • galectin 3(change from baseline after 48 weeks (optional after 96 weeks))

研究者

发起方
University of Jena
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christine Dawczynski,PhD

Head of Junior Research Group Nutritional Concepts

University of Jena

研究点 (2)

Loading locations...

相似试验